title: Current status and future perspectives of PSMA-targeted therapy in Europe: opportunity knocks.
authors.affiliation: Department of Nuclear Medicine, University Hospital Marburg, Marburg, Germany.
authors.forename: A
authors.initials: A
authors.lastname: Pfestroff
authors.affiliation: Department of Nuclear Medicine, University Hospital Marburg, Marburg, Germany. luster@med.uni-marburg.de.
authors.forename: M
authors.initials: M
authors.lastname: Luster
authors.affiliation: Department of Urology, University Hospital Freiburg, Freiburg, Germany.
authors.forename: C A
authors.initials: CA
authors.lastname: Jilg
authors.affiliation: Department of Urology, University Hospital Marburg, Marburg, Germany.
authors.forename: P J
authors.initials: PJ
authors.lastname: Olbert
authors.affiliation: Department of Urology, Saarland University Hospital, Homburg/Saar, Germany.
authors.forename: C H
authors.initials: CH
authors.lastname: Ohlmann
authors.affiliation: Department of Nuclear Medicine, University Hospital Würzburg, Würzburg, Germany.
authors.forename: M
authors.initials: M
authors.lastname: Lassmann
authors.affiliation: Department of Nuclear Medicine and Radiopharmacy, University Hospital Freiburg, Freiburg, Germany.
authors.forename: H R
authors.initials: HR
authors.lastname: Maecke
authors.affiliation: Department of Nuclear Medicine, Saarland University Hospital, Homburg/Saar, Germany.
authors.forename: S
authors.initials: S
authors.lastname: Ezziddin
authors.affiliation: Department of Nuclear Medicine, European Institute of Oncology, Milan, Italy.
authors.forename: L
authors.initials: L
authors.lastname: Bodei
mesh_terms: D000954:Antigens, Surface; D002986:Clinical Trials as Topic; D000077143:Docetaxel; D005060:Europe; D043425:Glutamate Carboxypeptidase II / Q000037:antagonists & inhibitors*; D006801:Humans; D008024:Ligands; D008187:Lutetium / Q000009:adverse effects / Q000627:therapeutic use; D008297:Male; D009842:Oligopeptides / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D064129:Prostatic Neoplasms, Castration-Resistant / Q000188:drug therapy / Q000532:radiotherapy*; D019275:Radiopharmaceuticals / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D043823:Taxoids / Q000009:adverse effects / Q000627:therapeutic use
chemical_list: D000954:Antigens, Surface; D008024:Ligands; D009842:Oligopeptides; D019275:Radiopharmaceuticals; D043823:Taxoids; D000077143:Docetaxel; D008187:Lutetium; C473848:FOLH1 protein, human; D043425:Glutamate Carboxypeptidase II